13D/13G Filings - Point72 Asset Management, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, ...17, 18, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-14
4:14 pm
Purchase
2023-12-31 13G Cybin Inc.
CYBN
Point72 Asset Management, L.P. 791,082
7.400%
791,082increase
(New Position)
Filing
History
2024-02-14
4:13 pm
Purchase
2023-12-31 13G Health Catalyst, Inc.
HCAT
Point72 Asset Management, L.P. 4,159,454
7.200%
1,334,524increase
(+47.24%)
Filing
History
2024-02-14
4:12 pm
Purchase
2023-12-31 13G Praxis Precision Medicines, Inc.
PRAX
Point72 Asset Management, L.P. 758,185
8.600%
758,185increase
(New Position)
Filing
History
2024-02-14
4:11 pm
Purchase
2023-12-31 13G Cogent Biosciences, Inc.
COGT
Point72 Asset Management, L.P. 5,243,623
6.100%
1,680,721increase
(+47.17%)
Filing
History
2024-02-14
4:10 pm
Purchase
2023-12-31 13G Elevation Oncology, Inc.
ELEV
Point72 Asset Management, L.P. 4,040,000
9.400%
1,918,830increase
(+90.46%)
Filing
History
2024-02-14
10:06 am
Sale
2023-12-31 13G Marinus Pharmaceuticals, Inc.
MRNS
Point72 Asset Management, L.P. 493,400
0.900%
-3,021,956decrease
(-85.96%)
Filing
History
2024-02-14
10:06 am
Sale
2023-12-31 13G GRITSTONE BIO INC
GRTSQ
Point72 Asset Management, L.P. 3,974,873
4.200%
-3,727,958decrease
(-48.40%)
Filing
History
2024-02-14
10:04 am
Sale
2023-12-31 13G FibroGen, Inc.
FGEN
Point72 Asset Management, L.P. 1,643,844
1.700%
-4,637,801decrease
(-73.83%)
Filing
History
2024-02-14
10:03 am
Sale
2023-12-31 13G Eos Energy Enterprises, Inc.
EOSE
Point72 Asset Management, L.P. 3,840,704
2.000%
-1,694,326decrease
(-30.61%)
Filing
History
2024-02-14
10:02 am
Sale
2023-12-31 13G Cidara Therapeutics, Inc.
CDTX
Point72 Asset Management, L.P. 62,511
1.400%
-130,889decrease
(-67.68%)
Filing
History
2024-02-14
10:02 am
Purchase
2023-12-31 13G Avalo Therapeutics, Inc.
AVTX
Point72 Asset Management, L.P. 2,500
0.300%
2,500increase
(New Position)
Filing
History
2024-02-14
10:01 am
Sale
2023-12-31 13G AnaptysBio, Inc.
ANAB
Point72 Asset Management, L.P. 788,545
3.000%
-1,335,655decrease
(-62.88%)
Filing
History
2024-02-14
08:56 am
Sale
2023-12-31 13G VistaGen Therapeutics, Inc.
VTGN
Point72 Asset Management, L.P. 822,334
3.000%
-743,495decrease
(-47.48%)
Filing
History
2024-02-14
07:16 am
Purchase
2023-12-31 13G FARFETCH LTD
FTCHQ
Point72 Asset Management, L.P. 20,383,303
5.800%
1,617,894increase
(+8.62%)
Filing
History
2024-02-14
07:15 am
Sale
2023-12-31 13G Protagonist Therapeutics, Inc.
PTGX
Point72 Asset Management, L.P. 2,613,453
4.500%
-572,624decrease
(-17.97%)
Filing
History
2024-02-14
07:15 am
Sale
2023-12-31 13G Amylyx Pharmaceuticals, Inc.
AMLX
Point72 Asset Management, L.P. 3,202,381
4.700%
-268,310decrease
(-7.73%)
Filing
History
2024-02-14
07:01 am
Purchase
2023-12-31 13G Semtech Corporation
SMTC
Point72 Asset Management, L.P. 1,684,160
2.600%
1,684,160increase
(New Position)
Filing
History
2024-02-14
07:01 am
Sale
2023-12-31 13G Syndax Pharmaceuticals, Inc.
SNDX
Point72 Asset Management, L.P. 2,834,499
3.300%
-685,903decrease
(-19.48%)
Filing
History
2024-02-14
07:00 am
Sale
2023-12-31 13G Biohaven Pharmaceutical Holding Company Ltd.
BHVN
Point72 Asset Management, L.P. 2,552,822
3.200%
-1,508,521decrease
(-37.14%)
Filing
History
2024-02-14
06:45 am
Sale
2023-12-31 13G Bionomics Limited
BNOX
Point72 Asset Management, L.P. 4,965,000
4.000%
-4,959,390decrease
(-49.97%)
Filing
History
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, ...17, 18, Next